Trials / Active Not Recruiting
Active Not RecruitingNCT03216733
SORT OUT X - Combo Stent Versus ORSIRO Stent
Randomized Clinical Comparison of a Combined Sirolimus Eluting and Endothelial Progenitor Cell COMBO Stent With a Sirolimus-eluting OSIRO Stent in Patients Treated With Percutaneous Coronary Intervention - The SORT-OUT X Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,148 (actual)
- Sponsor
- Aarhus University Hospital Skejby · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the Danish Organisation for randomised trials with clinical outcome (SORT OUT) is to compare the safety and efficacy of the ComboTM stent and Orsiro™ stent in the treatment of unselected patients with ischemic heart disease, using registry detection of clinically driven events.
Detailed description
Randomized Clinical Comparison of a Combined Sirolimus Eluting and endothelial progenitor cell COMBO Stent with a Sirolimus-eluting OSIRO stent in Patients Treated with Percutaneous Coronary Intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | COMBO | PCI with COMBO stent |
| DEVICE | ORSIRO | PCI with ORSIRO stent |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2018-11-30
- Completion
- 2028-12-31
- First posted
- 2017-07-13
- Last updated
- 2023-11-28
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03216733. Inclusion in this directory is not an endorsement.